Journal article · 2017 · Open access

OP14 A systematic review of cost-effectiveness evaluations of psychological therapies for schizophrenia and bipolar disorder

Deborah Buck, Gemma Shields, Jamie Elvidge, Karen Petra Hayhurst, Linda Mary Davies

Journal of Epidemiology & Community Health, A8.1–A8 · Published 1 September 2017 · DOI 10.1136/jech-2017-ssmabstracts.14

Open PDFView at the publisherCite this paper

In brief

“OP14 A systematic review of cost-effectiveness evaluations of psychological therapies for schizophrenia and bipolar disorder” is a 2017 journal article by Deborah Buck and 4 co-authors, published in Journal of Epidemiology & Community Health. OpenAlex counts 3 citations as of 20 November 2026. It is open access: the full text is free to read at Journal of Epidemiology & Community Health.

Citations
3
Most cited in
2018 (2)
Authors
5

Abstract

Background Schizophrenia and bipolar disorder (BD) are among the top twenty causes of disability. Costs of treatment and to society are substantial. NICE guidelines recommend psychological/psychosocial interventions are considered in response to acute episodes/recovery promotion. This review aims to assess cost-effectiveness of psychological interventions, determine robustness of the current evidence base, and identify evidence gaps. The key research question is: which psychological interventions are cost-effective, compared to usual care/alternative interventions, in schizophrenia or BD? Methods Electronic searches of PsycINFO, MEDLINE and Embase identified economic evaluations relating incremental cost to outcomes in an Incremental Cost-Effectiveness Ratio (ICER) published in English since 2000. Studies had to include: probability of cost-effectiveness at explicitly-defined thresholds; adults with schizophrenia/BD; any psychological intervention (e.g. psychological therapy, Improving Access to Psychological Therapies, integrated/collaborative care). Comparators could be routine practice, no intervention, or alternative psychological therapies. Searches were performed in August 2015 (updated January 2017). There were two screening stages with explicit inclusion criteria applied by 2 reviewers at each stage. Pre-specified data extraction/critical appraisal were performed. Results were summarised qualitatively. The review is registered on the PROSPERO database of systematic reviews. Results Of 3785 studies identified, 11 were included. All were integrated clinical and economic randomised controlled trials. All used cost-effectiveness and/or cost-utility analysis. The commonest intervention was CBT (6/11 studies). Measures of health benefit included QALYs (5/11), QLS 1/11), PANSS (2/11), MANSA (1/11), GAF (3/11), days with normal functioning (1/11), a working memory subscale (1/11), full vocational recovery (1/11), days with a bipolar episode (1/11). Follow-up ranged from 6 months to 5 years. 6/11 studies used provider perspectives for the primary analysis; the remainder considered societal perspectives. Interventions were cost-effective in most identified studies (9/11): ICERs ranged from dominant (intervention is cost-saving AND more effective) to £18 844 per QALY; the probability of cost-effectiveness ranged from 50% to 99.5% at chosen thresholds. The two studies deemed not cost-effective involved art/body psychotherapy and noted significant uncertainty in the data as a limitation. All studies had limitations, including missing data, sample sizes and challenges controlling for other medications/treatments received outside the trial intervention. Conclusion Although recommended in clinical guidelines, there was limited evidence about the cost-effectiveness of psychological therapy for schizophrenia/BD. Most included studies concluded psychological interventions for schizophrenia/BD are cost-effective. However policy implications are unclear due to methodological limitations and heterogeneity in populations and settings between studies. The review had some limitations including potential for English-language bias and limited time-horizon.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Buck, D., Shields, G., Elvidge, J., Hayhurst, K. P., & Davies, L. M. (2017). OP14 A systematic review of cost-effectiveness evaluations of psychological therapies for schizophrenia and bipolar disorder. Journal of Epidemiology & Community Health, A8.1–A8. https://doi.org/10.1136/jech-2017-ssmabstracts.14

MLA 9

Buck, Deborah, et al. “OP14 A systematic review of cost-effectiveness evaluations of psychological therapies for schizophrenia and bipolar disorder.” Journal of Epidemiology & Community Health, 2017, pp. A8.1–A8. https://doi.org/10.1136/jech-2017-ssmabstracts.14.

Chicago

Buck, Deborah, Gemma Shields, Jamie Elvidge, Karen Petra Hayhurst, and Linda Mary Davies. 2017. “OP14 A systematic review of cost-effectiveness evaluations of psychological therapies for schizophrenia and bipolar disorder.” Journal of Epidemiology & Community Health: A8.1–A8. https://doi.org/10.1136/jech-2017-ssmabstracts.14.

Harvard

Buck, D. et al. (2017) ‘OP14 A systematic review of cost-effectiveness evaluations of psychological therapies for schizophrenia and bipolar disorder’, Journal of Epidemiology & Community Health, pp. A8.1–A8. doi:10.1136/jech-2017-ssmabstracts.14.

IEEE

D. Buck, G. Shields, J. Elvidge, K. P. Hayhurst, and L. M. Davies, “OP14 A systematic review of cost-effectiveness evaluations of psychological therapies for schizophrenia and bipolar disorder,” Journal of Epidemiology & Community Health, pp. A8.1–A8, 2017, doi: 10.1136/jech-2017-ssmabstracts.14.

BibTeX

@article{buck2017systematic,
  title     = {{OP14 A systematic review of cost-effectiveness evaluations of psychological therapies for schizophrenia and bipolar disorder}},
  author    = {Buck, Deborah and Shields, Gemma and Elvidge, Jamie and Hayhurst, Karen Petra and Davies, Linda Mary},
  journal   = {Journal of Epidemiology \& Community Health},
  year      = {2017},
  pages     = {A8.1--A8},
  doi       = {10.1136/jech-2017-ssmabstracts.14},
  url       = {https://doi.org/10.1136/jech-2017-ssmabstracts.14}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life

  • psychotherapy
  • schizophrenia
  • bipolar disorder
  • cognitive behavioral therapy
  • art therapy
  • body psychotherapy
  • integrated care
  • collaborative care

Work with this paper

Most-cited papers in Economics, Econometrics and Finance

All highly cited Economics, Econometrics and Finance papers

Questions about this paper

How do I cite this paper in APA style?

Buck, D., Shields, G., Elvidge, J., Hayhurst, K. P., & Davies, L. M. (2017). OP14 A systematic review of cost-effectiveness evaluations of psychological therapies for schizophrenia and bipolar disorder. Journal of Epidemiology & Community Health, A8.1–A8. https://doi.org/10.1136/jech-2017-ssmabstracts.14

How many times has this paper been cited?

3 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Journal of Epidemiology & Community Health: sign in and open the PDF from this page.

Who wrote this paper?

Deborah Buck, Gemma Shields, Jamie Elvidge, Karen Petra Hayhurst, Linda Mary Davies.

What is the DOI of this paper?

10.1136/jech-2017-ssmabstracts.14, permanently at https://doi.org/10.1136/jech-2017-ssmabstracts.14. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.